Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss

Ítems similars

• Standard chemoradiation for glioblastoma results in progressive brain volume loss
  per: Prust, Morgan J., et al.
  Publicat: (2015)
• Low Incidence of Pseudoprogression by Imaging in Newly Diagnosed Glioblastoma Patients Treated With Cediranib in Combination With Chemoradiation
  per: Pinho, Marco C., et al.
  Publicat: (2014)
• AT-16 PHASE II STUDY OF TIVOZANIB, AN ORAL VEGFR INHIBITOR, IN PATIENTS WITH RECURRENT GLIOBLASTOMA
  per: Chandra, Vyshak, et al.
  Publicat: (2014)
• INCREASED PERFUSION DUE TO VASCULAR NORMALIZATION IMPROVES OXYGENATION AND SURVIVAL IN GLIOBLASTOMA PATIENTS TREATED WITH CEDIRANIB WITH OR WITHOUT CHEMORADIATION
  per: Batchelor, Tracy T., et al.
  Publicat: (2014)
• Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
  per: Batchelor, Tracy T., et al.
  Publicat: (2013)